DASAN MEDICHEM CO.,LTD Technology Information No . 1
Indication(적응증)
New drug(신약) (Ingredients)
Venous thromboembolism , Anticoagulant
IMD(개량신약) (Ingredients) Dabigatran
Biomedicine (Ingredients)
Item description - Dabigatran Capsule - Dose : 75mg, 110mg, 150mg
Development status - First stage of Clinical study in Korea
Plans for Out-Licensing or joint R&D or investment - Joint R&D, Corporate marketing
Patent - Avoiding patent of Original product WO 2003/07405 (composition patents)
Etc.
2
CDMO & CMO
Item description 1. CDMO & CMO (Contract Development and Manufacturing Organization) Formulation study – manufacturing apply – CMO production 2. Major equipment : Fluid bed systems - Glatt GmbH (Top and Bottom spray) Size : GPCG 1, GPCG 15, GPCG 120, GPCG 300 3. Major Technology : Micro Particle coating - Taste Masking - Controlled Release - Granulation - Pellet Development status
Plans for Out-Licensing or joint R&D or investment - Joint R&D, CDMO, CMO
Patent WO2010/137855 : MULTI-LAYER TABLET COMPRISING EFFERVESCENT LAYER WO/2007/013752 : PROCESSES FOR PREPARING SPHERICAL PANCREATIN-CONTAINING GRANULES WO/2003/026678 : NOVEL PHARMACEUTICAL COMPOSITION WITH IMPROVED DEFOAMING ACTIVITY